Quick Answer
Dare Bioscience, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.03 million for the year ending 2025.
- Dare Bioscience, Inc. showed an increase of +10,429.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $1.03 million | Fiscal year 2024: $9.8 thousand | Fiscal year 2023: $2.81 million | Fiscal year 2022: $10.00 million | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: